We are live on ! Find out more
CLRBZ

Cellectar Biosciences, Inc. Series A Warrants
CLRBZ

Delisted

CLRBZ was delisted on the 16th of April, 2021.

Back to rankings

4 hedge funds and large institutions have $174K invested in Cellectar Biosciences, Inc. Series A Warrants in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 2 → 4 (+2)

40% more capital invested

Capital invested by funds: $124K → $174K (+$50K)

Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$148K
2
UBS Group
UBS Group
Switzerland
+$100

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$111K +$148K +265,000 New
ICM
2
Ionic Capital Management
New York
$61K – – –
BA
3
BlackRock Advisors
Delaware
$2K – – –
UBS Group
4
UBS Group
Switzerland
– +$100 +180 New

CLRBZ Hedge Fund Activity: Q4 2016 in Review

4 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) for Q4 2016, worth a combined $174K — up 40% from $124K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CLRBZ positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $148K.

  • 4 institutional investors held Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) as of Q4 2016, up from 2 in Q3 2016.
  • Funds reported $174K of Cellectar Biosciences, Inc. Series A Warrants stock for Q4 2016, up 40% quarter-over-quarter.
  • 2 funds opened new Cellectar Biosciences, Inc. Series A Warrants positions in Q4 2016 and 0 closed out, a net change of +2 holders.
  • The largest Cellectar Biosciences, Inc. Series A Warrants buyer in Q4 2016 was Susquehanna International Group, an estimated $148K added.

Based on aggregated 13F filings for Q4 2016.